CVE-2020-2777

Description

Vulnerability in the Hyperion Financial Management product of Oracle Hyperion (component: Security). The supported version that is affected is 11.1.2.4. Difficult to exploit vulnerability allows high privileged attacker with network access via HTTP to compromise Hyperion Financial Management. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Hyperion Financial Management accessible data. CVSS 3.0 Base Score 4.2 (Integrity impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:H/PR:H/UI:R/S:U/C:N/I:H/A:N).

4.2
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.43%
Vendor Advisory oracle.com
Affected: Oracle Corporation Hyperion Financial Management
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-2777?
CVE-2020-2777 has been scored as a medium severity vulnerability.
How to fix CVE-2020-2777?
To fix CVE-2020-2777, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-2777 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-2777 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-2777?
CVE-2020-2777 affects Oracle Corporation Hyperion Financial Management.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.